{
  "ticker": "MRK",
  "year": 2022,
  "quarter": 2,
  "last_updated": "2025-04-15T12:45:33.214155",
  "count": 63,
  "transactions": [
    {
      "id": 5241,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Karachun Rita A",
      "reporting_owner_cik": "0001601572",
      "reporting_owner_position": "Sr. VP Fince-Global Controller",
      "transaction_date": "2022-05-04",
      "transaction_shares": "949",
      "transaction_price": "87.10",
      "transaction_type": "M",
      "shares_after_transaction": "41428.972"
    },
    {
      "id": 5253,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Garay Arpa",
      "reporting_owner_cik": "0001916360",
      "reporting_owner_position": "SVP Human Health Global Mktg.",
      "transaction_date": "2022-05-04",
      "transaction_shares": "907",
      "transaction_price": "87.10",
      "transaction_type": "M",
      "shares_after_transaction": "2368"
    },
    {
      "id": 5254,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "LeCointe-Cephas Lisa",
      "reporting_owner_cik": "0001854644",
      "reporting_owner_position": "SVP Chief Ethics & Com Officer",
      "transaction_date": "2022-05-04",
      "transaction_shares": "813",
      "transaction_price": "87.10",
      "transaction_type": "M",
      "shares_after_transaction": "3942.781"
    },
    {
      "id": 5261,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Klobuchar Michael A",
      "reporting_owner_cik": "0001871957",
      "reporting_owner_position": "EVP - Chief Strategy Officer",
      "transaction_date": "2022-05-04",
      "transaction_shares": "885",
      "transaction_price": "87.10",
      "transaction_type": "M",
      "shares_after_transaction": "15774.93"
    },
    {
      "id": 5264,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Oosthuizen Johannes Jacobus",
      "reporting_owner_cik": "0001916310",
      "reporting_owner_position": "SVP, U.S. Market",
      "transaction_date": "2022-05-04",
      "transaction_shares": "907",
      "transaction_price": "87.10",
      "transaction_type": "M",
      "shares_after_transaction": "14960.881"
    },
    {
      "id": 17051,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Karachun Rita A",
      "reporting_owner_cik": "0001601572",
      "reporting_owner_position": "Sr. VP Fince-Global Controller",
      "transaction_date": "2022-05-04",
      "transaction_shares": "949",
      "transaction_price": "87.10",
      "transaction_type": "M",
      "shares_after_transaction": "41428.972"
    },
    {
      "id": 17064,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Garay Arpa",
      "reporting_owner_cik": "0001916360",
      "reporting_owner_position": "SVP Human Health Global Mktg.",
      "transaction_date": "2022-05-04",
      "transaction_shares": "907",
      "transaction_price": "87.10",
      "transaction_type": "M",
      "shares_after_transaction": "2368"
    },
    {
      "id": 17065,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "LeCointe-Cephas Lisa",
      "reporting_owner_cik": "0001854644",
      "reporting_owner_position": "SVP Chief Ethics & Com Officer",
      "transaction_date": "2022-05-04",
      "transaction_shares": "813",
      "transaction_price": "87.10",
      "transaction_type": "M",
      "shares_after_transaction": "3942.781"
    },
    {
      "id": 17074,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Klobuchar Michael A",
      "reporting_owner_cik": "0001871957",
      "reporting_owner_position": "EVP - Chief Strategy Officer",
      "transaction_date": "2022-05-04",
      "transaction_shares": "885",
      "transaction_price": "87.10",
      "transaction_type": "M",
      "shares_after_transaction": "15774.93"
    },
    {
      "id": 17078,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Oosthuizen Johannes Jacobus",
      "reporting_owner_cik": "0001916310",
      "reporting_owner_position": "SVP, U.S. Market",
      "transaction_date": "2022-05-04",
      "transaction_shares": "907",
      "transaction_price": "87.10",
      "transaction_type": "M",
      "shares_after_transaction": "14960.881"
    },
    {
      "id": 35405,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Karachun Rita A",
      "reporting_owner_cik": "0001601572",
      "reporting_owner_position": "Sr. VP Fince-Global Controller",
      "transaction_date": "2022-05-04",
      "transaction_shares": "949",
      "transaction_price": "87.10",
      "transaction_type": "M",
      "shares_after_transaction": "41428.972"
    },
    {
      "id": 35422,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Garay Arpa",
      "reporting_owner_cik": "0001916360",
      "reporting_owner_position": "SVP Human Health Global Mktg.",
      "transaction_date": "2022-05-04",
      "transaction_shares": "907",
      "transaction_price": "87.10",
      "transaction_type": "M",
      "shares_after_transaction": "2368"
    },
    {
      "id": 35425,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "LeCointe-Cephas Lisa",
      "reporting_owner_cik": "0001854644",
      "reporting_owner_position": "SVP Chief Ethics & Com Officer",
      "transaction_date": "2022-05-04",
      "transaction_shares": "813",
      "transaction_price": "87.10",
      "transaction_type": "M",
      "shares_after_transaction": "3942.781"
    },
    {
      "id": 35440,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Klobuchar Michael A",
      "reporting_owner_cik": "0001871957",
      "reporting_owner_position": "EVP - Chief Strategy Officer",
      "transaction_date": "2022-05-04",
      "transaction_shares": "885",
      "transaction_price": "87.10",
      "transaction_type": "M",
      "shares_after_transaction": "15774.93"
    },
    {
      "id": 35444,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Oosthuizen Johannes Jacobus",
      "reporting_owner_cik": "0001916310",
      "reporting_owner_position": "SVP, U.S. Market",
      "transaction_date": "2022-05-04",
      "transaction_shares": "907",
      "transaction_price": "87.10",
      "transaction_type": "M",
      "shares_after_transaction": "14960.881"
    },
    {
      "id": 5257,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Karachun Rita A",
      "reporting_owner_cik": "0001601572",
      "reporting_owner_position": "Sr. VP Fince-Global Controller",
      "transaction_date": "2022-05-03",
      "transaction_shares": "902",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "40788.972"
    },
    {
      "id": 5258,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "LeCointe-Cephas Lisa",
      "reporting_owner_cik": "0001854644",
      "reporting_owner_position": "SVP Chief Ethics & Com Officer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "452",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "3284.781"
    },
    {
      "id": 5260,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Oosthuizen Johannes Jacobus",
      "reporting_owner_cik": "0001916310",
      "reporting_owner_position": "SVP, U.S. Market",
      "transaction_date": "2022-05-03",
      "transaction_shares": "773",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "14434.881"
    },
    {
      "id": 5262,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Garay Arpa",
      "reporting_owner_cik": "0001916360",
      "reporting_owner_position": "SVP Human Health Global Mktg.",
      "transaction_date": "2022-05-03",
      "transaction_shares": "773",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "1682"
    },
    {
      "id": 5269,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Klobuchar Michael A",
      "reporting_owner_cik": "0001871957",
      "reporting_owner_position": "EVP - Chief Strategy Officer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "773",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "15270.93"
    },
    {
      "id": 5281,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Williams David Michael",
      "reporting_owner_cik": "0001820958",
      "reporting_owner_position": "EVP,Chief Info&Digital Officer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "427",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "9409.757"
    },
    {
      "id": 5283,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Li Dean Y",
      "reporting_owner_cik": "0001837016",
      "reporting_owner_position": "Executive VP & President, MRL",
      "transaction_date": "2022-05-03",
      "transaction_shares": "773",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "16838.945"
    },
    {
      "id": 5284,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Litchfield Caroline",
      "reporting_owner_cik": "0001854928",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-03",
      "transaction_shares": "773",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "27799.2881"
    },
    {
      "id": 17069,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Karachun Rita A",
      "reporting_owner_cik": "0001601572",
      "reporting_owner_position": "Sr. VP Fince-Global Controller",
      "transaction_date": "2022-05-03",
      "transaction_shares": "902",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "40788.972"
    },
    {
      "id": 17070,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "LeCointe-Cephas Lisa",
      "reporting_owner_cik": "0001854644",
      "reporting_owner_position": "SVP Chief Ethics & Com Officer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "452",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "3284.781"
    },
    {
      "id": 17073,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Oosthuizen Johannes Jacobus",
      "reporting_owner_cik": "0001916310",
      "reporting_owner_position": "SVP, U.S. Market",
      "transaction_date": "2022-05-03",
      "transaction_shares": "773",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "14434.881"
    },
    {
      "id": 17075,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Garay Arpa",
      "reporting_owner_cik": "0001916360",
      "reporting_owner_position": "SVP Human Health Global Mktg.",
      "transaction_date": "2022-05-03",
      "transaction_shares": "773",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "1682"
    },
    {
      "id": 17084,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Klobuchar Michael A",
      "reporting_owner_cik": "0001871957",
      "reporting_owner_position": "EVP - Chief Strategy Officer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "773",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "15270.93"
    },
    {
      "id": 17097,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Williams David Michael",
      "reporting_owner_cik": "0001820958",
      "reporting_owner_position": "EVP,Chief Info&Digital Officer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "427",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "9409.757"
    },
    {
      "id": 17099,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Li Dean Y",
      "reporting_owner_cik": "0001837016",
      "reporting_owner_position": "Executive VP & President, MRL",
      "transaction_date": "2022-05-03",
      "transaction_shares": "773",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "16838.945"
    },
    {
      "id": 17100,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Litchfield Caroline",
      "reporting_owner_cik": "0001854928",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-03",
      "transaction_shares": "773",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "27799.2881"
    },
    {
      "id": 35433,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Karachun Rita A",
      "reporting_owner_cik": "0001601572",
      "reporting_owner_position": "Sr. VP Fince-Global Controller",
      "transaction_date": "2022-05-03",
      "transaction_shares": "902",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "40788.972"
    },
    {
      "id": 35434,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "LeCointe-Cephas Lisa",
      "reporting_owner_cik": "0001854644",
      "reporting_owner_position": "SVP Chief Ethics & Com Officer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "452",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "3284.781"
    },
    {
      "id": 35438,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Oosthuizen Johannes Jacobus",
      "reporting_owner_cik": "0001916310",
      "reporting_owner_position": "SVP, U.S. Market",
      "transaction_date": "2022-05-03",
      "transaction_shares": "773",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "14434.881"
    },
    {
      "id": 35441,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Garay Arpa",
      "reporting_owner_cik": "0001916360",
      "reporting_owner_position": "SVP Human Health Global Mktg.",
      "transaction_date": "2022-05-03",
      "transaction_shares": "773",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "1682"
    },
    {
      "id": 35452,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Klobuchar Michael A",
      "reporting_owner_cik": "0001871957",
      "reporting_owner_position": "EVP - Chief Strategy Officer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "773",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "15270.93"
    },
    {
      "id": 35467,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Williams David Michael",
      "reporting_owner_cik": "0001820958",
      "reporting_owner_position": "EVP,Chief Info&Digital Officer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "427",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "9409.757"
    },
    {
      "id": 35470,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Li Dean Y",
      "reporting_owner_cik": "0001837016",
      "reporting_owner_position": "Executive VP & President, MRL",
      "transaction_date": "2022-05-03",
      "transaction_shares": "773",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "16838.945"
    },
    {
      "id": 35471,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Litchfield Caroline",
      "reporting_owner_cik": "0001854928",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-03",
      "transaction_shares": "773",
      "transaction_price": "87.65",
      "transaction_type": "M",
      "shares_after_transaction": "27799.2881"
    },
    {
      "id": 5242,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Oosthuizen Johannes Jacobus",
      "reporting_owner_cik": "0001916310",
      "reporting_owner_position": "SVP, U.S. Market",
      "transaction_date": "2022-05-01",
      "transaction_shares": "866",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "14088.881"
    },
    {
      "id": 5244,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Klobuchar Michael A",
      "reporting_owner_cik": "0001871957",
      "reporting_owner_position": "EVP - Chief Strategy Officer",
      "transaction_date": "2022-05-01",
      "transaction_shares": "866",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "14924.93"
    },
    {
      "id": 5255,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "LeCointe-Cephas Lisa",
      "reporting_owner_cik": "0001854644",
      "reporting_owner_position": "SVP Chief Ethics & Com Officer",
      "transaction_date": "2022-05-01",
      "transaction_shares": "640",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "3052.781"
    },
    {
      "id": 5259,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Litchfield Caroline",
      "reporting_owner_cik": "0001854928",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-01",
      "transaction_shares": "866",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "27453.2881"
    },
    {
      "id": 5271,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Garay Arpa",
      "reporting_owner_cik": "0001916360",
      "reporting_owner_position": "SVP Human Health Global Mktg.",
      "transaction_date": "2022-05-01",
      "transaction_shares": "866",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "1156"
    },
    {
      "id": 5275,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Li Dean Y",
      "reporting_owner_cik": "0001837016",
      "reporting_owner_position": "Executive VP & President, MRL",
      "transaction_date": "2022-05-01",
      "transaction_shares": "1061",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "16588.945"
    },
    {
      "id": 5280,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Karachun Rita A",
      "reporting_owner_cik": "0001601572",
      "reporting_owner_position": "Sr. VP Fince-Global Controller",
      "transaction_date": "2022-05-01",
      "transaction_shares": "928",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "40204.972"
    },
    {
      "id": 5286,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Williams David Michael",
      "reporting_owner_cik": "0001820958",
      "reporting_owner_position": "EVP,Chief Info&Digital Officer",
      "transaction_date": "2022-05-01",
      "transaction_shares": "577",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "9180.757"
    },
    {
      "id": 17052,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Oosthuizen Johannes Jacobus",
      "reporting_owner_cik": "0001916310",
      "reporting_owner_position": "SVP, U.S. Market",
      "transaction_date": "2022-05-01",
      "transaction_shares": "866",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "14088.881"
    },
    {
      "id": 17055,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Klobuchar Michael A",
      "reporting_owner_cik": "0001871957",
      "reporting_owner_position": "EVP - Chief Strategy Officer",
      "transaction_date": "2022-05-01",
      "transaction_shares": "866",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "14924.93"
    },
    {
      "id": 17066,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "LeCointe-Cephas Lisa",
      "reporting_owner_cik": "0001854644",
      "reporting_owner_position": "SVP Chief Ethics & Com Officer",
      "transaction_date": "2022-05-01",
      "transaction_shares": "640",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "3052.781"
    },
    {
      "id": 17071,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Litchfield Caroline",
      "reporting_owner_cik": "0001854928",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-01",
      "transaction_shares": "866",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "27453.2881"
    },
    {
      "id": 17086,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Garay Arpa",
      "reporting_owner_cik": "0001916360",
      "reporting_owner_position": "SVP Human Health Global Mktg.",
      "transaction_date": "2022-05-01",
      "transaction_shares": "866",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "1156"
    },
    {
      "id": 17091,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Li Dean Y",
      "reporting_owner_cik": "0001837016",
      "reporting_owner_position": "Executive VP & President, MRL",
      "transaction_date": "2022-05-01",
      "transaction_shares": "1061",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "16588.945"
    },
    {
      "id": 17096,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Karachun Rita A",
      "reporting_owner_cik": "0001601572",
      "reporting_owner_position": "Sr. VP Fince-Global Controller",
      "transaction_date": "2022-05-01",
      "transaction_shares": "928",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "40204.972"
    },
    {
      "id": 17102,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Williams David Michael",
      "reporting_owner_cik": "0001820958",
      "reporting_owner_position": "EVP,Chief Info&Digital Officer",
      "transaction_date": "2022-05-01",
      "transaction_shares": "577",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "9180.757"
    },
    {
      "id": 35407,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Oosthuizen Johannes Jacobus",
      "reporting_owner_cik": "0001916310",
      "reporting_owner_position": "SVP, U.S. Market",
      "transaction_date": "2022-05-01",
      "transaction_shares": "866",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "14088.881"
    },
    {
      "id": 35410,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Klobuchar Michael A",
      "reporting_owner_cik": "0001871957",
      "reporting_owner_position": "EVP - Chief Strategy Officer",
      "transaction_date": "2022-05-01",
      "transaction_shares": "866",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "14924.93"
    },
    {
      "id": 35426,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "LeCointe-Cephas Lisa",
      "reporting_owner_cik": "0001854644",
      "reporting_owner_position": "SVP Chief Ethics & Com Officer",
      "transaction_date": "2022-05-01",
      "transaction_shares": "640",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "3052.781"
    },
    {
      "id": 35435,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Litchfield Caroline",
      "reporting_owner_cik": "0001854928",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-01",
      "transaction_shares": "866",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "27453.2881"
    },
    {
      "id": 35454,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Garay Arpa",
      "reporting_owner_cik": "0001916360",
      "reporting_owner_position": "SVP Human Health Global Mktg.",
      "transaction_date": "2022-05-01",
      "transaction_shares": "866",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "1156"
    },
    {
      "id": 35459,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Li Dean Y",
      "reporting_owner_cik": "0001837016",
      "reporting_owner_position": "Executive VP & President, MRL",
      "transaction_date": "2022-05-01",
      "transaction_shares": "1061",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "16588.945"
    },
    {
      "id": 35466,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Karachun Rita A",
      "reporting_owner_cik": "0001601572",
      "reporting_owner_position": "Sr. VP Fince-Global Controller",
      "transaction_date": "2022-05-01",
      "transaction_shares": "928",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "40204.972"
    },
    {
      "id": 35473,
      "issuer_name": "Merck & Co., Inc.",
      "reporting_owner": "Williams David Michael",
      "reporting_owner_cik": "0001820958",
      "reporting_owner_position": "EVP,Chief Info&Digital Officer",
      "transaction_date": "2022-05-01",
      "transaction_shares": "577",
      "transaction_price": "88.69",
      "transaction_type": "M",
      "shares_after_transaction": "9180.757"
    }
  ]
}